The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
Procore Technologies, Inc.
PCOR · the NYSE · USD · Market cap $11.5B · 4,421 employees
Procore Technologies, Inc., together with its subsidiaries, provides a cloud-based construction management platform and related products and services in the United States and internationally.
PASS · Titan Ethical · score 70.0Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 18:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price75.60 USD at the 5 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.00)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $49.50 to $66.63, base estimate $57.94 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders insiders sold, $830,915, latest filing 2026-10-05
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.00, read 2026-11-05
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Procore Technologies, Inc. holds its Accumulation at $75.60. Consolidating, no directional conviction, held for 8 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 8 days |
| Price at the screen | $75.60 |
| Valuation | N/A trailing · 31.07 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.75 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 3.23% | Below 33% | Interest-bearing debt is just 3.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 1.90% | Below 33% | Cash held in interest-bearing accounts and securities is 1.9% of assets, under the one-third limit. | Pass |
| Receivables | 34.32% | Below 49% | Money owed to the company is 34.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.58% | Below 5% | Only 1.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Procore Technologies, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 3%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PCOR's ethical verdict changes
Today PCOR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 5 Nov 2026: it trades above our $57.94 fair value estimate, 15.80% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 30.5% above the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits −8% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $57.94, with a range of $49.50 to $66.63, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsConstruction software still laying its foundations
Picture a skyscraper going up with every subcontractor using their own spreadsheets. Procore offers the single cloud platform that pulls owners, contractors and architects onto one live set of drawings and budgets. Revenue is rising at 16 percent, the ethical screen is cleared, and the shares sit 19 percent below our fair value, yet the company is still losing money at a 6 percent margin with a matching negative return on equity.
That combination explains the "none" rating. Forward earnings sit at 21.8 times, analysts like the story and push a $69 median target, but the absence of profits means any valuation multiple rests on hopes rather than delivered cash. Without a clear moat the business must keep spending heavily just to hold share in a fragmented market.
The real risk is that construction spending slows or competitors copy the workflow before margins turn positive. Currency moves and project delays can hit revenue quickly, and negative returns leave little room for error if growth falters. Analysis, not advice.
| Forward P/E | 31.1xpriced for continued growth |
| EPS, trailing | -0.26 |
| EPS, forward | 2.43 |
| Revenue growth | +15.8%steady growth |
| Profit margin | -2.7%currently unprofitable |
| Return on equity | -3.1%not currently earning a positive return on equity |
| FCF yield | 2.65% |
| Debt to equity | 0.05minimal debt: a conservative balance sheet |
| Current ratio | 1.17adequate liquidity, worth monitoring |
| Beta | 0.75steadier than the market |
| Short interest, float | 0.16% |
| 52-week range | 38.03 - 82.32 |
| Market cap | $11.5B |
| Employees | 4,421 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradePCOR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 35%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (19 analysts) rates it none, with a mean price target of $69. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- HubSpot (HUBS) Earnings Expected to Grow: Should You Buy? Yahoo Finance · 9d ago
- Procore Technologies (PCOR) Earnings Expected to Grow: Should You Buy? Yahoo Finance · 10d ago
- SMARTER Act Could Lift Unity Stock And Other High Skill Tech Employers Yahoo Finance · 14d ago
- 2 Reasons PCOR is risky and 1 stock to buy instead Yahoo Finance · 14d ago
- Procore Launches Voice-First AI Mobile App Built for the Jobsite Yahoo Finance · 16d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | O Connor Kevin J | Dir | S - Sale | 15,384 | $830,915 |
| 2026-09-10 | Courtemanche Craig F. Jr. | Chairman of the Board | S - Sale+OE | 56,122 | $3,001,357 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $50.10 | -13.1% | · | $869 | -13.1% |
| 2 months | $47.19 | -7.7% | · | $923 | -7.7% |
| 3 months | $57.03 | -23.6% | · | $764 | -23.6% |
| 6 months | $76.83 | -43.3% | · | $567 | -43.3% |
| 1 year | $67.14 | -35.1% | · | $649 | -35.1% |
| 2 years | $67.18 | -35.2% | · | $648 | -35.2% |
| 3 years | $64.95 | -33.0% | · | $671 | -33.0% |
| 5 years | $83.99 | -48.2% | · | $519 | -48.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever PCOR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.